Rezolute, Inc. (RZLT) financial statements (2021 and earlier)

Company profile

Business Address 201 REDWOOD SHORES PARKWAY, SUITE 315
REDWOOD CITY, CA 94065
State of Incorp. DE
Fiscal Year End June 30
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
Q2
9/30/2019
Q1
6/30/2019
Q4
3/31/2019
Q3
12/31/2018
Q2
9/30/2018
Q1
6/30/2018
Q4
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments18221215002
Cash and cash equivalents18221215002
Receivables 0     
Assets held-for-sale, not part of disposal group    0  
Other current assets   0000
Other undisclosed current assets241    
Total current assets:20261215012
Noncurrent Assets
Operating lease, right-of-use asset01  
Property, plant and equipment0000 00
Intangible assets, net (including goodwill)0000000
Intangible assets, net (excluding goodwill)0000000
Deposits noncurrent assets     00
Deferred costs     00
Other undisclosed noncurrent assets0000   
Total noncurrent assets:1100000
TOTAL ASSETS:21271215013
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:2211222
Accounts payable11     
Employee-related liabilities1011111
Interest and dividends payable   0000
Other undisclosed accounts payable and accrued liabilities  0(0)111
Debt0000043
Other liabilities100  00
Other undisclosed current liabilities3476111
Total current liabilities:6687376
Noncurrent Liabilities
Long-term debt and lease obligation00  5  
Long-term debt, excluding current maturities    5  
Operating lease, liability00  
Liabilities, other than long-term debt0000 00
Other liabilities0000 00
Other undisclosed noncurrent liabilities  24200
Total noncurrent liabilities:0024700
Total liabilities:6611111086
Stockholders' equity
Stockholders' equity attributable to parent152125(10)(6)(4)
Preferred stock   31   
Common stock0000000
Additional paid in capital15315212897929190
Accumulated deficit(139)(132)(127)(124)(102)(98)(94)
Total stockholders' equity:152125(10)(6)(4)
TOTAL LIABILITIES AND EQUITY:21271215013

Income statement (P&L) ($ in millions)

12/31/2019
Q2
9/30/2019
Q1
6/30/2019
Q4
3/31/2019
Q3
12/31/2018
Q2
9/30/2018
Q1
6/30/2018
Q4
Gross profit:(0)(0)(1)(0)(0)(0)0
Operating expenses(7)(5)(3)(17)(3)(3)(11)
Other undisclosed operating income (loss)001000(0)
Operating loss:(7)(5)(3)(17)(3)(3)(11)
Nonoperating income (expense) 00(3)(1)(1)(1)
Investment income, nonoperating  (0)0000
Gain on contract termination  0 0  
Interest and debt expense  (4)(0)(1)(1)(1)
Net loss:(7)(5)(7)(20)(5)(4)(13)
Other undisclosed net income attributable to parent0 40111
Net loss attributable to parent:(7)(5)(3)(20)(4)(3)(12)
Other undisclosed net loss available to common stockholders, basic   (2)   
Net loss available to common stockholders, diluted:(7)(5)(3)(22)(4)(3)(12)

Comprehensive Income ($ in millions)

12/31/2019
Q2
9/30/2019
Q1
6/30/2019
Q4
3/31/2019
Q3
12/31/2018
Q2
9/30/2018
Q1
6/30/2018
Q4
Net loss:(7)(5)(7)(20)(5)(4)(13)
Comprehensive loss:(7)(5)(7)(20)(5)(4)(13)
Other undisclosed comprehensive loss, net of tax, attributable to parent  (2)    
Comprehensive loss, net of tax, attributable to parent:(7)(5)(10)(20)(5)(4)(13)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: